new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Pfizer Inc
Pfizer Inc And Renovis Inc
Pfizer Inc Products Inc
Pfizer Inc Pfizer Products Inc
  

Pfizer Inc patents (2011 archive)

Recent patent applications related to Pfizer Inc. Pfizer Inc is listed as an Agent/Assignee. Note: Pfizer Inc may have other listings under different names/spellings. We're not affiliated with Pfizer Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "P" | Pfizer Inc-related inventors




Date Pfizer Inc patents (2011 archive) (updated weekly) - BOOKMARK this page
12/08/11Pharmaceutical formulation
12/08/11Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylmino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1)
12/01/11Immunogenic lhrh compositions and methods relating thereto
12/01/11High dosage doramectin formulation
12/01/11Pyrrolo[2,3-d]pyrimidine compounds
11/24/11Parapoxvirus vectors
11/24/11Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis
11/17/11Morpholine compounds
11/10/11Antibodies to ccr2
10/13/11Substituted isoxazoline derivatives
10/06/11Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
09/29/11Rotary supply joint, rotary timing valve and product handling apparatus
09/29/11Process for forming amorphous atorvastatin
09/22/11Substituted heteroaryls
09/22/11Antibodies with ph dependent antigen binding
09/22/111-oxa-8-azaspiro [4,5] decabe-8-carboxamide compounds as faah inhibitors
09/15/11Apparatus for handling capsules and capsule processing equipment including such an apparatus
09/15/11Novel lactams as beta secretase inhibitors
09/01/11Compositions and methods for treating female sexual dysfunction
09/01/11Phosphate derivatives of substituted benzoxazoles
08/25/11Peptide analogues
08/04/11Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions
07/28/11Methods of generating genetic predictors employing dna markers and quantitative trait data
07/21/11Device for dispensing a plurality of unitary doses of dry powder, and inhaler comprising such device
07/21/11Hydroxamic acid derivatives useful as antibacterial agents
07/21/11Tetrahydrofuranyl sulfonamides and pharmaceutical compositions thereof
07/14/11Stable liquid antibody formulation
07/14/11Oxopiperdinyl and pyranyl sulfonamides and pharmaceutical compositions thereof
07/14/11Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, alpha-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
07/07/11Osteopontin antibodies
07/07/11Sulfonyl amide derivatives for the treatment of abnormal cell growth
06/23/11Treatment of incontinence
06/23/11Torque teno virus (ttv) isolates and compositions
06/16/11Pharmaceutical compositions of atorvastatin
06/16/116 substituted 2- heterocyclylamino pyrazine compounds as chk-1 inhibitors
06/16/113-aminocyclopentanecarboxamides as chemokine receptor agonists
06/16/11Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors
06/09/11Pyrrolo[2,3-d]pyrimidine compounds
05/26/11Methods of using genetic markers and related epistatic interactions
05/19/11Process for preparing chiral compounds
05/12/11N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
05/12/11Hepatitis c virus inhibitors
05/05/11Cd40 antibody formulation and methods
05/05/11Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
05/05/11Synergistic composition of (-)-hydroxycitric acid with monoterpene and a method to enhance satiety
04/28/11Novel compounds as casein kinase inhibitors
04/28/11Treatment of chronic prostatitis
04/21/11Substituted heterocyclic derivatives and their pharmaceutical use and compositions
04/21/111,2,4-triazole derivatives and their use as oxytocin antagonists
04/14/11Transdermal system for varenicline
03/24/11Methods for the preparation of hcv polymerase inhibitors
03/17/11Preparation of pregabalin and related compounds
03/17/11Infectious clones of torque teno virus
03/17/11Improved capsule with air-vents
03/10/111-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1h-pyrazolo[4,3-d]pyrimidin-5-yl) piperidine-4-carboxylic acid and salts thereof
03/10/114-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
03/03/11Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
03/03/114-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
03/03/11Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
03/03/114-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
02/24/11Novel class of spiro piperidines for the treatment of neurodegenerative diseases
02/17/11Fused phenyl amido heterocyclic compounds
02/17/11Gabapentin for the treatment of overactive bladder, stress incontinence and bph
02/17/11Infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
02/17/11Polymorphs of a c-met/hgfr inhibitor
02/17/11Infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
02/10/11Pyrimidine derivatives for the treatment of abnormal cell growth
02/03/11Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
02/03/11Indazole derivatives
02/03/11Pyrazolospiroketone acetyl-coa carboxylase inhibitors
01/27/11Gpr 119 modulators
01/27/11Methods of culturing lawsonia intracellularis
01/20/11Combination treatment for non-hematologic malignancies
01/13/11Transfer line
01/13/11Capsule formation
01/13/11Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
01/06/11Methods, dosage forms and kits for administering ziprasidone without food







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Pfizer Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Pfizer Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';